Sabato Biohaven Ltd. ha presentato dati preclinici su BHV-1420 durante una sessione orale alla Kidney Week 2026 dell'American ...
Biohaven Ltd. a présenté samedi des données précliniques sur BHV-1420 lors d’une présentation orale à l’occasion de la Kidney Week 2026 de l’American Society of Nephrology , à ...
Biohaven Ltd. presentó el sábado datos preclínicos sobre el BHV-1420 durante una ponencia oral en la Kidney Week 2026 de la ...
Biohaven Ltd. hat am Samstag auf der Kidney Week 2026 der American Society of Nephrology in Denver, Colorado, in einem ...
Biohaven Ltd. presenteerde zaterdag tijdens een mondelinge presentatie op Kidney Week 2026 van de American Society of Nephrology in Denver, Colorado, preklinische gegevens over BHV-1420.
In a laboratory diagnostic assay, BHV-1420 brought 88% of anti-PLA2R-positive patient samples (n=59) below the clinical threshold for positivity, indicating its potential to recognize and target ...
Biohaven Ltd. (NYSE: BHVN) (Biohaven) on Saturday presented preclinical data for BHV-1420 in an oral presentation at the ...
Biohaven Ltd. (NYSE: BHVN) (Biohaven) on Saturday presented preclinical data for BHV-1420 in an oral presentation at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado.
Ce guide a été rédigé sous la direction de Dr Thomas Klein, MD en collaboration avec Conseil consultatif médical de Kantesti AI, avec notamment la contribution du professeur Dr Hans Weber et la ...
This guide was written under the leadership of Dr. Thomas Klein, MD in collaboration with the Kantesti AI Medical Advisory Board, including contributions from Prof. Dr. Hans Weber and medical review ...
3 Center for Molecular and Clinical Immunology, College of Medicine, Chang Gung University, Taoyuan, Taiwan 4 Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Taoyuan, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results